Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall avandiaThe diabetes drug Avandia has been linked to an increased death risk due to adverse cardiovascular events, according to a new analysis of more than 40 studies and nearly 28,000 patients. The analysis, published in the New England Journal of Medicine in May 2007, indicated that patients treated with Avandia for Type 2 diabetes have a significantly higher risk of dying from a heart-related problem compared to patients who are treated with another diabetes drug or a placebo.
If you are concerned about Avandia’s death risk, you should consult with a physician as soon as possible. If you have been injured as a result of taking Avandia, a qualified defective drug lawyer can determine if you are eligible to seek reimbursement for your losses.
What Diabetics Should Know About Avandia
Type 2 diabetes affects up to 20 million Americans, and an estimated one million American patients are currently taking Avandia. The U.S. Food and Drug Administration (FDA) has required that new safety information be added to the drug’s label to warn users and healthcare professionals of Avandia’s death risk and other serious side effects.
People with Type 2 diabetes already have an increased risk of cardiovascular problems, and taking a drug that provides an increased risk of heart attack and other heart problems could lead to deadly complications. In fact, the new meta-analysis of Avandia data revealed a 30% to 40% increased risk of heart attack in patients treated with Avandia, some of which proved fatal.
FDA Criticized Over Avandia Death & Heart Attack Risk
When the NEJM published the new safety analysis, the FDA came under harsh new criticism over Avandia’s death risk and heart attack risk—with documents revealing that the FDA was aware of Avandia’s risks as early as 2000. Still, GlaxoSmithKline was allowed to continue marketing—and reaping exorbitant profits from sales of—Avandia.
Evidence shows that Glaxo knew about the dangers, including heart attack and death, associated with its blockbuster drug. Because the company sacrificed safety to profits, it may be held liable for damages suffered by those harmed by Avandia. Recoverable damages often include medical costs, loss of enjoyment of life, and mental anguish, among other things.
To learn more about your legal rights from an experienced product liability attorney, contact us today.
A government run diabetes trial was halted 18 months early after a safety analysis revealed an increased risk of death in patients whose blood sugar levels dipped too low.
The 10,000 patient trial was examining the effectiveness of aggressive ...
A new study published in the Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avandia—that is, it carries a significantly increased risk of heart failure, heart attack, and death.
Ob...
At the urging of the Food and Drug Administration, GlaxoSmithKline is adding a new warning to its once-popular diabetes drug Avandia . An increased risk of heart attack will now appear ...